ESR1 and breast carcinoma: In particular, miR-206 was reported to be associated with estrogen signals by targeting ESR1 (ERα) of breast carcinoma cell lines [8], and miR-221/222 could regulate estrogenic signals through ERα, resulting in the development of anti-estrogen resistant breast cancer [9,10].